Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter Capitelli
Peter Capitelli
Memorial Sloan Kettering Cancer Center
Carcinoma
Radioimmunotherapy
Medicine
Immunology
Radiation therapy
4
Papers
257
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I/II radioimmunotherapy trial with iodine 131 labeled monoclonal antibody G250 in metastatic renal cell carcinoma
1998
Clinical Cancer Research
Chaitanya R. Divgi
Neil H. Bander
Andrew M. Scott
Joseph ODonoghue
George Sgouros
Sydney Welt
Ronald D. Finn
Francesca Morrissey
Peter Capitelli
Jeanne M. Williams
Devie Deland
Aparna Nakhre
Egbert Oosterwijk
Seza A. Gulec
Martin C. Graham
Steven M. Larson
Lloyd J. Old
Show All
Source
Cite
Save
Citations (148)
Pharmacokinetic Model of Iodine-131-G250 Antibody in Renal Cell Carcinoma Patients
1998
The Journal of Nuclear Medicine
Angela Loh
George Sgouros
Joseph A. O'Donoghue
Devie Deland
Dennis Puri
Peter Capitelli
John L. Humm
Steven M. Larson
Lloyd J. Old
Chaitanya R. Divgi
Show All
Source
Cite
Save
Citations (10)
Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma.
1995
Clinical Cancer Research
Chaitanya R. Divgi
Andrew M. Scott
Seza A. Gulec
E K Broussard
N Levy
C Young
Peter Capitelli
Farhad Daghighian
J. M. Williams
Ronald D. Finn
Show All
Source
Cite
Save
Citations (24)
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma
1995
The Journal of Nuclear Medicine
Chaitanya R. Divgi
Andrew M. Scott
L Dantis
Peter Capitelli
Kathleen Siler
Susan Hilton
Ronald D. Finn
Nancy E. Kemeny
David P. Kelsen
Lale Kostakoglu
Jeffrey Schlom
Steven M. Larson
Show All
Source
Cite
Save
Citations (75)
1